Tiziana Life Sciences
TLSA
23 hedge funds and large institutions have $6.02M invested in Tiziana Life Sciences in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 7 closing their positions.
7% more capital invested
Capital invested by funds: $5.63M → $6.02M (+$385K)
0% more funds holding
Funds holding: 23 → 23 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.09% less ownership
Funds ownership: 5.98% → 5.88% (-0.09%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$76.4K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$38.8K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$19.5K |
| 4 |
State Street
Boston,
Massachusetts
|
+$18.4K |
| 5 |
Barclays
London,
United Kingdom
|
+$15.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$75K |
| 2 |
HSBC Holdings
London,
United Kingdom
|
-$53.1K |
| 3 |
Jane Street
New York
|
-$47K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$39K |
| 5 |
BlackRock
New York
|
-$29K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
BlackRock
New York
| – | -$29K | -30,619 | Closed |
|
27
Goldman Sachs
New York
| – | -$24K | -25,370 | Closed |
|
TLSA Hedge Fund Activity: Q1 2022 in Review
23 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q1 2022, worth a combined $6.02M — up 6.8% from $5.63M a quarter earlier.
Fund positioning in TLSA was balanced in Q1 2022: 7 funds opened new positions, 7 closed out, 4 added to existing stakes and 4 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $76.4K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $75K sold.
- 23 institutional investors held Tiziana Life Sciences (TLSA) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $6.02M of Tiziana Life Sciences stock for Q1 2022, up 6.8% quarter-over-quarter.
- 7 funds opened new Tiziana Life Sciences positions in Q1 2022 and 7 closed out, a net change of 0 holders.
- The largest Tiziana Life Sciences buyer in Q1 2022 was JP Morgan Chase, an estimated $76.4K added.
- The largest Tiziana Life Sciences seller in Q1 2022 was Renaissance Technologies, an estimated $75K sold.
Based on aggregated 13F filings for Q1 2022.